Exploitation of a recently identified information disclosure flaw in Check Point’s VPN technology has rapidly increased, affecting multiple versions of various Check Point products. The vulnerability allows attackers to access sensitive information and make lateral movements on a network. First identified in May, exploitation activity reportedly started as early as April. As of 5 June, 782 IPs worldwide targeted the flaw, and it is recommended organisations patch Check Point immediately.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
